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intervention. No correlation between the coronary status 
and the risk score or cardiovascular risk profile was found. 
 Conclusions: The high prevalence of asymptomatic CAD in 
lung transplant candidates without correlation to a common 
clinical risk score supports the important role of coronary an-
giography for the assessment of coronary artery status. This 
approach might prevent cardiovascular events and improve 
long-term survival after transplantation. 
 © 2015 S. Karger AG, Basel 
 Introduction 
 The recently published adult lung and heart-lung 
transplant report of the International Society for Heart 
and Lung Transplantation (ISHLT) emphasizes that the 
age distribution of lung transplant recipients has shifted 
to the elderly: since 1985, the median age of recipients has 
gradually increased; almost 66% of lung transplant recip-
ients are now aged 45–65 years  [1] . The treatment with 
calcineurin inhibitors, which is a class of immunosup-
pressive drugs commonly used in all lung transplant re-
cipients, aggravates the cardiovascular risk profile by in-
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 Abstract 
 Background: An atherosclerotic disease burden sufficient to 
put lung transplant candidates at risk for end-organ disease 
after transplantation is considered to be a relative contrain-
dication for lung transplantation.  Objectives:  The aim of this 
study was to assess our current practice of cardiac workup 
by coronary angiography in lung transplant candidates  ≥ 50 
years of age.  Methods:  We retrospectively analyzed 50 con-
secutive lung transplant candidates  ≥ 50 years of age in 
which coronary angiography was performed at the Univer-
sity Hospital Zurich (2009–2013). For every patient, the risk 
of developing an acute coronary event was estimated by us-
ing a recalibrated version of the PROCAM study calculator for 
the Swiss population.  Results: The median estimated risk of 
developing an acute coronary event within 10 years in the 
study cohort (n = 50) was 4.2% (interquartile range 1.9–7.6), 
which is considered to be a low risk. Sixteen percent of pa-
tients were considered to be at intermediate risk. In 66% of 
patients, coronary angiography showed no coronary artery 
disease (CAD). In 28% of patients, CAD without significant 
stenosis was diagnosed. In 6% of patients, significant coro-
nary stenosis was detected requiring percutaneous coronary 
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creasing the incidence of hypertension, diabetes mellitus, 
and dyslipidemia  [2] . In order to prevent cardiovascular 
events (especially myocardial infarction), a careful evalu-
ation of the coronary arterial status of elderly transplant 
candidates becomes even more important, since age is a 
well-known additional cardiovascular risk factor. More-
over, the prevalence of cardiovascular risk factors in-
creases with age.
 An atherosclerotic disease burden sufficient to put the 
lung transplant candidate at risk for end-organ disease 
after transplantation is considered to be a relative contra-
indication for lung transplantation  [3] . The assessment of 
cardiovascular status, especially the presence of coronary 
artery disease (CAD), therefore is an important part of 
the pre-transplant workup. This is also stated in a consen-
sus document for the selection of lung transplant candi-
dates by the ISHLT  [3] , although the definitive clinical 
evidence of the prognostic impact is still lacking  [4, 5] .
 Coronary angiography can detect abnormal morphol-
ogy of coronary arteries that can be treated and, at least 
in part, may affect long-term outcome following lung 
transplantation  [2] . To date, the cardiovascular assess-
ment at our Lung Transplant Program at the University 
Hospital Zurich includes medical history, electrocardiog-
raphy, echocardiography, and, in lung transplant candi-
dates over the age of 50 years, routine coronary angiogra-
phy. The aim of this study was to assess our current prac-
tice of cardiac workup among lung transplant candidates 
and possibly update this practice if shortcomings are 
 detected.
 Methods 
 We audited the current clinical practice at our institution eval-
uating lung transplant candidates aged >50 years for CAD by cor-
onary angiography. The coronary arterial status was routinely as-
sessed by a coronary angiography and classified into 3 categories. 
First, if no coronary plaques could be detected, the coronary status 
was defined as normal. Second, in the presence of wall irregulari-
ties (coronary sclerosis) or plaques of  ≤ 50% stenosis, CAD without 
significant stenosis was diagnosed. Third, the presence of one or 
more stenoses of >50% was defined as significant CAD. According 
to guidelines  [6, 7] , functional assessment of the severity of coro-
nary stenosis by fractional flow reserve was not routinely per-
formed.
 We retrospectively analyzed 50 consecutive patients aged 50 
years or older in which coronary angiography was performed dur-
ing assessment for lung transplantation at the University Hospital 
Zurich in the years 2009–2013.
 For every patient, the risk of developing an acute coronary 
event was estimated by using a recalibrated version of the 
 PROCAM  study calculator for the Swiss population, known in 
Switzerland as the ‘AGLA risk calculator’  [8, 9] . We hypothesized 
that a correlation between the estimated risk of cardiovascular 
events and the coronary arterial status could be found, and conse-
quently, the indication for performing coronary angiography in 
lung transplantation candidates may be optimized. All data are 
shown as medians and interquartile ranges (IQR).
 The local research ethics committee granted approval for this 
study (Ethics Committee of the Canton of Zurich; KEK-ZH No. 
2013-0460).
 Results 
 The study group consisted of 50 consecutive patients, 
aged 50 years or older, in which coronary angiography 
was performed during assessment for lung transplanta-
tion at the University Hospital Zurich in the years 2009–
2013.
 In the study cohort (n = 50), the median age was 59.0 
years (IQR 54.5–62.0), and 32 patients (64%) were male. 
The most frequent diagnosis leading to lung transplanta-
tion in the study group was chronic obstructive pulmo-
nary disease (COPD; 54%) followed by pulmonary fibro-
sis (idiopathic pulmonary fibrosis and usual interstitial 
pneumonia; 26%). A smoking history and arterial hyper-
tension were the most prevalent cardiovascular risk fac-
tors (76 and 40%, respectively). Baseline characteristics of 
patients are shown in  table 1 .
 The median estimated risk of developing an acute cor-
onary event within 10 years was 4.2% (IQR 1.9–7.6), 
which is considered to be a low risk according to the cur-
 Table 1.  Baseline characteristics of the included patients
Sex
Male 32 (64)
Female 18 (36)
Age, years 59 (54.5–62)
Diagnosis
COPD 27 (54)
IPF/UIP 13 (26)
Others 10 (20)
Cardiovascular risk factors
Smoking history 38 (76)
Hypertension 20 (40)
Dyslipidemia 6 (12)
Adiposity 11 (22)
Diabetes 6 (12)
Family history of CAD 7 (14)
AGLA risk calculator, % 4.2 (1.9–7.6)
Values are n (%) or median (interquartile range). IPF = Idio-
pathic pulmonary fibrosis; UIP = usual interstitial pneumonia.
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.4
7.
22
 - 
5/
27
/2
01
6 
2:
54
:1
5 
PM
 Coronary Angiography for Lung 
Transplant Candidates 
 Respiration 2015;89:107–111 
DOI: 10.1159/000368368
109
rent Swiss guidelines (www.agla.ch). Just 8 patients (16%) 
had a score of  ≥ 10%, which is considered to be an inter-
mediate risk.
 In about two thirds of patients (66%), coronary angi-
ography showed no CAD. However, in 28% of patients, 
CAD without significant stenosis was diagnosed. In 3 pa-
tients (6%), significant coronary stenosis was detected re-
quiring percutaneous coronary intervention with stent-
ing.  Figure 1 shows the findings of coronary angiography.
 Only 3 of 8 patients (37%) with a risk score  ≥ 10% had 
pathological coronary angiography, and 14 of 17 patients 
(82%) with pathological coronary angiography were clas-
sified as low risk for coronary events using the AGLA risk 
calculator.
 The prevalence of cardiovascular risk factors in the 
subgroup with normal coronary angiography compared 
to those with CAD did not differ significantly.
 In the subgroup with normal coronary angiography, 
the median risk according to the AGLA risk calculator 
was 4.2% (IQR 2.2–7.7), whereas in the subgroup with 
pathological findings in the coronary angiography, the 
median risk was 4.4% (IQR 1.5–6.7).  Table 2 summarizes 
the findings of the two subgroups.
 Discussion 
 A clinical audit is a systematic review of procedures 
intended to improve quality and outcome of patient care 
 [10] . This audit carried out at our institution aimed to 
evaluate the current practice in the assessment of coro-
nary status of lung transplant candidates aged 50 years or 
older. An analysis of the obtained data revealed several 
interesting results.
 Firstly, asymptomatic CAD was present in almost a 
third of lung transplant candidates aged 50 years or older, 
which represents a high prevalence. This finding con-
firms data from previously published series  [11, 12] . Of 
interest, the median risk estimated by the AGLA calcula-
tor was low with just a few patients identified as having 
an intermediate and high risk for coronary events.
 Secondly, the AGLA risk score was not correlated with 
coronary status. The median score in the group with nor-
mal coronaries was almost identical to the score of those 
patients with coronary pathologies as assessed by the gold 
standard method, coronary angiography. With the ex-
ception of dyslipidemia for which the low number of pa-
tients precludes further conclusions, no significant differ-
ences in the presence of cardiovascular risk factors were 
found between the two groups. In addition, only a minor-
ity of patients considered to be at least at intermediate risk 
showed pathologies of the coronary vessels, and most of 
the patients with coronary atherosclerosis were classified 
as low risk as assessed by the risk score using parameters 
available before the invasive assessment with coronary 
angiography.
 The power of these results may be limited by the fact 
that the epidemiological PROCAM risk calculator was 
6%
28%
66%
 Fig. 1. Coronary angiography in lung transplant candidates. Per-
centage of patients with normal coronary arteries (light grey), with 
nonsignificant CAD (dark grey), and significant CAD (black). 
 Table 2.  Characteristics of patients with normal coronaries and 
coronary artery disease
Normal
(n = 33)
Pathological
(n =  17)
Sex
Male 18 (55) 14 (82)
Female 15 (45) 3 (18)
Age, years 59 (54–60) 60 (57–62)
Diagnosis
COPD 17 (52) 10 (59)
IPF/UIP 7 (21) 6 (35)
Others 9 (27) 1 (6)
Cardiovascular risk factors
Smoking history 24 (73) 14 (82)
Hypertension 14 (42) 6 (35)
Dyslipidemia 2 (6) 4 (24)
Adipositas 8 (24) 3 (18)
Diabetes 5 (15) 1 (6)
Family history of CAD 5 (15) 2 (12)
AGLA risk calculator, % 4.2 (2.2–7.7) 4.4 (1.5–6.7)
Values are n (%) or median (interquartile range). IPF = Idio-
pathic pulmonary fibrosis; UIP = usual interstitial pneumonia.
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developed to predict the 10-year risk of myocardial in-
farction in the general population. However, several stud-
ies  [13, 14] suggested that epidemiological risk scores 
might correlate with subclinical atherosclerosis and, as 
such, might be used as a surrogate marker of coronary 
anatomy.
 Thirdly, the main pulmonary diagnosis for which pa-
tients were referred for lung transplant assessment seems 
not to be associated with an increased prevalence of CAD. 
This is an unexpected finding since the diagnosis of 
COPD itself is considered to portend additional cardio-
vascular risk due to the common risk factor of smoking 
 [15, 16] . The findings from our study might be biased by 
the fact that the included patients did not have typical 
cardiovascular symptoms prior to referral, while symp-
tomatic patients probably underwent assessment for cor-
onary disease elsewhere before routine assessment for 
lung transplantation at our institution. Conversely, in our 
study, CAD was more frequently found in patients with a 
diagnosis of pulmonary fibrosis. One might assume that 
systemic inflammatory mechanisms also involve the cor-
onary vessels as previously reported  [17] . However, the 
small sample size of our retrospective study is not ade-
quately powered for a definitive conclusion.
 Our results have several implications. The commonly 
used recalibrated PROCAM risk calculator does not seem 
to be able to predict coronary artery risk in the highly se-
lected population of lung transplant candidates. In our 
cohort, the risk score showed low positive (0.40) and neg-
ative (0.66) predictive values. Designed as a clinical audit, 
our study was not adequately powered to quantify the 
predictive performance of the PROCAM risk calculator. 
However, these data confirm that an epidemiological 
score, which was validated for the general population, 
cannot be directly translated to selected patient sub-
groups and its routine use in this setting cannot be recom-
mended.
 In order to prevent cardiovascular events (e.g. myocar-
dial infarction) and improve long-term survival after lung 
transplantation, the assessment of coronary artery status 
before transplantation is an important part of the pre-
transplant workup. In the presence of coronary athero-
sclerosis, patients undergoing lung transplantation are 
considered to be at an increased risk for end-organ disease 
and, therefore, risk factors should be treated aggressively.
 Considering these facts, especially the relatively high 
prevalence of asymptomatic CAD in lung transplantation 
candidates and the lack of correlation with a common 
clinical risk score, a careful evaluation of coronary status 
by angiography seems to be a reasonable approach in our 
view.
 The high diagnostic power that is achieved, the possi-
bility of treating significant stenosis and performing ad-
vanced hemodynamic measurements by a single proce-
dure, and the low risk profile at high-volume centers  [18] 
offer significant advantages of the invasive technique as 
compared to noninvasive methods (CT, SPECT, PET, 
and MRI).
 In addition, our data suggest that in light of these ad-
vantages, cardiac evaluation by coronary angiography 
should probably be extended even to patients below the 
age of 50 years when assessed for lung transplantation. 
Where an age cutoff should be set for the performance of 
a coronary angiography in this specific population with 
end-stage pulmonary disease would be a matter of inves-
tigation in a larger future study. 
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